CAMP Earnings Date: Nov 5, 2026 (Estimated) — CAMP4 Therapeutics Corporation
NASDAQ · Healthcare · Biotechnology
Updated
When is CAMP's next earnings date?
CAMP4 Therapeutics Corporation (CAMP) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.18 on revenue of $2.4M.
How did CAMP do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), CAMP4 Therapeutics Corporation posted EPS of -$0.58 versus the -$0.21 estimate, a miss of 163.6%. Revenue was $1.8M against a $1.6M estimate. The stock's 1-day post-earnings move was +20.9%.
How much does CAMP stock move after earnings?
CAMP beat EPS estimates in 0 of its last 8 reported quarters. Over the last 6 reports the stock moved an average of 14.6% (up or down) in the day after earnings.
About CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.21 | -0.58 | -163.64% | $1.8M | ❌ Miss | +20.89% | -1.11% | -5.56% |
| 2026-05-07 | Q1 2026 | -0.21 | -0.32 | -52.38% | $1.3M | ❌ Miss | +2.77% | +0.92% | -5.76% |
| 2026-03-05 | Q4 2025 | -0.30 | -0.87 | -190.00% | $348,000 | ❌ Miss | +12.50% | +37.25% | +9.56% |
| 2025-11-06 | Q3 2025 | -0.48 | -0.55 | -14.58% | $795,000 | ❌ Miss | -4.49% | -4.04% | -17.98% |
| 2024-01-09 | Q3 2024 | -0.03 | -0.22 | -633.33% | $53.6M | ❌ Miss | — | — | — |
| 2023-10-05 | Q2 2024 | — | -0.11 | — | $61.7M | ❌ Miss | -35.29% | -45.13% | -40.27% |
| 2023-07-10 | Q1 2024 | 0.04 | 0.01 | -75.00% | $70.9M | ❌ Miss | -11.80% | -14.47% | -24.55% |
| 2022-12-20 | 0.05 | -0.06 | — | $78.9M | ❌ Miss | — | — | — |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q4 FY23 · $53.6M total
| Segment | Share | Revenue | YoY | Q2 FY22 | Q3 FY22 | Q4 FY22 | Q1 FY23 |
|---|---|---|---|---|---|---|---|
| Product | 58.2% | $31.2M | -41.5% | $39.4M | $45.7M | $53.3M | $50.5M |
| Application Subscriptions And Other Services | 41.8% | $22.4M | -12.3% | $25.3M | $27.1M | $25.6M | $28.0M |
By region
Q4 FY23 · $53.6M total
| Segment | Share | Revenue | YoY | Q2 FY22 | Q3 FY22 | Q4 FY22 | Q1 FY23 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 54.5% | $29.2M | -42.0% | $40.4M | $46.2M | $50.4M | $48.4M |
| EMEA | 26.5% | $14.2M | — | — | — | — | — |
| Asia Pacific | 9.0% | $4.8M | +72.5% | $5.2M | $5.6M | $2.8M | $4.8M |
| Latin America | 7.2% | $3.9M | -57.1% | $6.0M | $8.2M | $9.0M | $8.8M |
| All Other | 2.8% | $1.5M | -15.1% | $589K | $534K | $1.8M | $1.4M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.